| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $0 | — |
| SG&A Expense | $91K | -76.0% |
| Operating Income | -$91K | +76.0% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$91K | +0.2% |
| Income Tax | $0 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | +776.3% |
| Current Assets | $1.5M | +808.1% |
| Total Assets | $1.5M | +808.1% |
| Current Liabilities | $673K | +1.2% |
| Long-term Debt | $0 | — |
| Total Liabilities | $673K | +1.2% |
| Stockholders' Equity | $793K | +257.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$120K | -122.9% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $1.4M | +604.1% |
| Free Cash Flow | -$120K | -122.9% |
| Net Income | -$91K | +0.2% |
| EPS (Basic) | -$0.03 | -110.0% |
| EPS (Diluted) | -$0.03 | -111.1% |